July 9, 2018
MIT researchers have developed a new technique to 3-D print magnetic robots that could one day be used as biomedical devices, reports Erik Olsen for Quartz. “The engineers have enabled the bots to roll, crawl, jump, and even snap together like a Venus flytrap to grasp a pill and then roll away with it,” explains Olsen.
Financial Times reporter Hannah Kuchler writes that researchers from MIT and a number of other institutions have called for a moratorium on editing inheritable human genes. Kuchler writes that the researchers called for the establishment of “an international framework on the conditions in which such editing could be allowed.”
CSAIL researchers have developed a new robotic gripper that contains an origami skeleton, enabling the device to open and close like a flower and grasp a variety of delicate and heavy objects, reports James Vincent for The Verge “By combining this foldable skeleton with the soft exterior, we get the best of both worlds,” explains Prof. Daniela Rus, director of CSAIL.
TechCrunch reporter Brian Heater writes that researchers at CSAIL and Harvard have developed a soft robotic gripper that can both handle delicate objects and lift items up to 100 times its own weight. “The gripper itself is made of an origami-inspired skeletal structure, covered in either fabric or a deflated balloon,” explains Heater.
Gizmodo reporter Ed Cara writes about a study by MIT researchers have finds “inactive” ingredients in pills could trigger a patient’s allergies or intolerances. “We’re not saying that everyone should stop taking these medications,” explains Prof. Giovanni Traverso. “But people with an allergy or intolerance should definitely have the opportunity to find out if they have to worry about certain medications.”
MIT researchers have found that companies with experienced technologists on their boards tend to have better financial outcomes, reports Sara Castellanos and Angus Loten for The Wall Street Journal. “Directors on digitally savvy boards have an understanding, tested by experience, of how digital technologies impact the way that companies will succeed in the next decade,” explains research scientist Stephanie Woerner.
MIT researchers have found that many pills contain “inactive” ingredients that could be troublesome for patients, reports Richard Harris for NPR. Prof. Giovanni Traverso explains that if a patient with lactose intolerance takes a pill containing lactose, “it's probably not going to manifest in any significant symptoms. But as the number of pills you're taking [increases], then certainly you might cross that threshold."